litlas
Log inCreate account

Gianluca Pirozzi

Active 2004–2021

51
Papers
21,219
Citations
45
h-index
51
i10-index

Citations

Citations per year for Gianluca Pirozzi1982: 1 citations1986: 2 citations2005: 8 citations2006: 4 citations2007: 4 citations2008: 1 citations2009: 3 citations2011: 1 citations2012: 2 citations2013: 11 citations2014: 41 citations2015: 83 citations2016: 134 citations2017: 249 citations2018: 290 citations2019: 1,253 citations2020: 1,565 citations2021: 1,544 citations2022: 1,328 citations2023: 1,018 citations2024: 1,371 citations2025: 698 citations2026: 13 citations1983–1985: no citations, so these years are not shown1987–2004: no citations, so these years are not shown2010: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,895 citing papers, 21.6% of this breakdownUnited Kingdom: 637 citing papers, 7.2% of this breakdownGermany: 593 citing papers, 6.7% of this breakdownItaly: 585 citing papers, 6.7% of this breakdownCanada: 421 citing papers, 4.8% of this breakdownChina: 409 citing papers, 4.7% of this breakdownJapan: 409 citing papers, 4.7% of this breakdownFrance: 407 citing papers, 4.6% of this breakdownNetherlands: 312 citing papers, 3.5% of this breakdownSpain: 290 citing papers, 3.3% of this breakdownBelgium: 232 citing papers, 2.6% of this breakdownSwitzerland: 226 citing papers, 2.6% of this breakdown
0%21.6%Other 27%

Institutions

Fields

  • Medicine90.2%
  • Immunology and Microbiology5.8%
  • Biochemistry, Genetics and Molecular Biology1.8%
  • Neuroscience1%
  • Health Professions0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other0.8%

Topics

  • Asthma and respiratory diseases15.9%
  • Dermatology and Skin Diseases15.5%
  • Allergic Rhinitis and Sensitization12.7%
  • Psoriasis: Treatment and Pathogenesis4.8%
  • Sinusitis and nasal conditions4.5%
  • IL-33, ST2, and ILC Pathways4.5%
  • Other42.1%

Coauthors

All papers

Open in search
  1. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Authors: Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper - New England Journal of Medicine 2018 cited by 1,929

  2. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - New England Journal of Medicine 2016 cited by 2,045

  3. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

    Authors: Claus Bachert, Joseph K. Han, Martin Desrosiers, Peter W. Hellings, Nikhil Amin, Stella E. Lee, Joaquim Mullol, Leon S. Greos, John V. Bosso, Tanya M. Laidlaw, Anders Cervin, Jorge Máspero, Claire Hopkins, Heidi Olze, Giorgio Walter Canonica, Pierluigi Paggiaro, Seong Cho, Wytske J. Fokkens, Shigeharu Fujieda, Mei Zhang, Xin Lu, Chunpeng Fan, Steven Draikiwicz, Siddhesh Kamat, Asif Khan, Gianluca Pirozzi, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, David M. Weinreich, Neil Stahl, George D. Yancopoulos, Leda Mannent - The Lancet 2019 cited by 1,479

  4. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

    Authors: Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham, Jennifer Clay Cather, Jamie Weisman, David M. Pariser, Eric L. Simpson, Kim Papp, Hyuck-Ki Hong, Diana Rubel, Peter Foley, Errol P. Prens, C.E.M. Griffiths, Takafumi Etoh, Pedro Herranz, Ramón M. Pujol, Jacek C. Szepietowski, Karel Ettler, Lajos Kemény, Xiaoping Zhu, Bolanle Akinlade, Thomas Hultsch, Vera Mastey, Abhijit Gadkari, Laurent Eckert, Nikhil Amin, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Brad Shumel - The Lancet 2017 cited by 1,243

  5. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

    Authors: Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, Jorge Máspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D. Hamilton, Brian N. Swanson, Asif Khan, Jingdong Chao, Heribert Staudinger, Gianluca Pirozzi, Christian Antoni, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Ariel Teper - New England Journal of Medicine 2018 cited by 1,162

  6. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

    Authors: Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, Mayte Suárez‐Fariñas, Marius Ardeleanu, Hitokazu Esaki, Maria Suprun, Yeriel Estrada, Hui Xu, Xiangyu Peng, Jonathan I. Silverberg, Alan Menter, James G. Krueger, Rick Zhang, Usman Chaudhry, Brian N. Swanson, Neil M.H. Graham, Gianluca Pirozzi, George D. Yancopoulos, Jennifer D. Hamilton - Journal of Allergy and Clinical Immunology 2018 cited by 678

  7. Targeting key proximal drivers of type 2 inflammation in disease

    Authors: Namita A. Gandhi, Brandy L. Bennett, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos - Nature Reviews Drug Discovery 2015 cited by 746

  8. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

    Authors: Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Mark Boguniewicz, Lawrence Sher, Melinda Gooderham, Lisa A. Beck, Emma Guttman‐Yassky, David M. Pariser, Andrew Blauvelt, Jamie Weisman, Benjamin Lockshin, Thomas Hultsch, Qin Zhang, Mohamed Kamal, John D. Davis, Bolanle Akinlade, Heribert Staudinger, Jennifer D. Hamilton, Neil M.H. Graham, Gianluca Pirozzi, Abhijit Gadkari, Laurent Eckert, Neil Stahl, George D. Yancopoulos, Marcella Ruddy, Ashish Bansal - JAMA Dermatology 2019 cited by 509

  9. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

    Authors: Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin - New England Journal of Medicine 2014 cited by 1,405

  10. Commonality of the IL-4/IL-13 pathway in atopic diseases

    Authors: Namita A. Gandhi, Gianluca Pirozzi, Neil M.H. Graham - Expert Review of Clinical Immunology 2017 cited by 479

  11. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

    Authors: Sally E. Wenzel, Mario Castro, Jonathan Corren, Jorge Máspero, Lin Wang, Bingzhi Zhang, Gianluca Pirozzi, E. Rand Sutherland, Robert R. Evans, Vijay N. Joish, Laurent Eckert, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Mariana Louis‐Tisserand, Ariel Teper - The Lancet 2016 cited by 880

  12. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

    Authors: Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith, Kristian Reich, Michael J. Cork, Allen Radin, Q. Zhang, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Thomas Hultsch, Z. Chen, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel - British Journal of Dermatology 2017 cited by 475

  13. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

    Authors: Ikuo Hirano, Evan S. Dellon, Jennifer D. Hamilton, Margaret H. Collins, Kathryn A. Peterson, Mirna Chehade, Alain Schoepfer, Ekaterina Safroneeva, Marc E. Rothenberg, Gary W. Falk, Yehudith Assouline-Dayan, Qiong Zhao, Zhen Chen, Brian N. Swanson, Gianluca Pirozzi, Leda Mannent, Neil M.H. Graham, Bolanle Akinlade, Neil Stahl, George D. Yancopoulos, Allen Radin - Gastroenterology 2019 cited by 451

  14. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

    Authors: Sally E. Wenzel, Linda Ford, David S. Pearlman, Sheldon L. Spector, Lawrence Sher, Franck Skobieranda, Lin Wang, Stéphane Kirkesseli, Ross E. Rocklin, Brian C. Bock, Jennifer D. Hamilton, Jeffrey E. Ming, Allen Radin, Neil Stahl, George D. Yancopoulos, Neil M.H. Graham, Gianluca Pirozzi - New England Journal of Medicine 2013 cited by 1,312

  15. Conjunctivitis in dupilumab clinical trials

    Authors: Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg - British Journal of Dermatology 2019 cited by 422

  16. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

    Authors: Claus Bachert, Leda Mannent, Robert M. Naclerio, Joaquim Mullol, Berrylin J. Ferguson, Philippe Gevaert, Peter W. Hellings, Lixia Jiao, Lin Wang, Robert R. Evans, Gianluca Pirozzi, Neil M.H. Graham, Brian N. Swanson, Jennifer D. Hamilton, Allen Radin, Namita A. Gandhi, Neil Stahl, George D. Yancopoulos, E. Rand Sutherland - JAMA 2016 cited by 785

  17. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

    Authors: Jennifer D. Hamilton, Mayte Suárez‐Fariñas, Nikhil Dhingra, Irma Cardinale, Xuan Li, Ana Kostić, Jeffrey E. Ming, Allen Radin, James G. Krueger, Neil M.H. Graham, George D. Yancopoulos, Gianluca Pirozzi, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2014 cited by 469

  18. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

    Authors: Mette Deleuran, Diamant Thaçi, Lisa A. Beck, Marjolein de Bruin‐Weller, Andrew Blauvelt, Seth Forman, Robert Bissonnette, Kristian Reich, Weily Soong, Iftikhar Hussaın, Peter Foley, Michihiro Hide, Jean‐David Bouaziz, Joel M. Gelfand, Lawrence Sher, Marie L. A. Schuttelaar, Chen Wang, Zhen Chen, Bolanle Akinlade, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Heribert Staudinger, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu - Journal of the American Academy of Dermatology 2019 cited by 256

  19. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases

    Authors: Jennifer D. Hamilton, Sivan Harel, Brian N. Swanson, William R. Brian, Zhen Chen, Megan S. Rice, Nikhil Amin, Marius Ardeleanu, Allen Radin, Brad Shumel, Marcella Ruddy, Naimish Patel, Gianluca Pirozzi, Leda Mannent, Neil M.H. Graham - Clinical & Experimental Allergy 2021 cited by 185

  20. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis

    Authors: Gil Yosipovitch, Matthew Reaney, Vera Mastey, Laurent Eckert, Adeline Abbé, Lauren Nelson, M. Clark, Nicole Williams, Z. Chen, Marius Ardeleanu, Bolanle Akinlade, Neil M.H. Graham, Gianluca Pirozzi, Heribert Staudinger, Stefan Plaum, Allen Radin, A. Gadkari - British Journal of Dermatology 2019 cited by 378

  21. Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

    Authors: Margitta Worm, Eric L. Simpson, Diamant Thaçi, Robert Bissonnette, J.‐P. Lacour, Stefan Beissert, Makoto Kawashima, Carlos Ferrándiz, Catherine Smith, Lisa A. Beck, Kuo‐Chen Chan, Zhen Chen, Bolanle Akinlade, Thomas Hultsch, Heribert Staudinger, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - JAMA Dermatology 2019 cited by 206

  22. IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

    Authors: Chris Callewaert, Teruaki Nakatsuji, Rob Knight, Tomasz Kościółek, Alison Vrbanac, Paul F. Kotol, Marius Ardeleanu, Thomas Hultsch, Emma Guttman‐Yassky, Robert Bissonnette, Jonathan I. Silverberg, James G. Krueger, Alan Menter, Neil M.H. Graham, Gianluca Pirozzi, Jennifer D. Hamilton, Richard L. Gallo - Journal of Investigative Dermatology 2019 cited by 217

  23. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

    Authors: Diamant Thaçi, Eric L. Simpson, Lisa A. Beck, Thomas Bieber, Andrew Blauvelt, Kim Papp, Weily Soong, Margitta Worm, Jacek C. Szepietowski, Howard Sofen, Makoto Kawashima, Richard Wu, Steven P. Weinstein, Neil M.H. Graham, Gianluca Pirozzi, Ariel Teper, E. Rand Sutherland, Vera Mastey, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - The Lancet 2015 cited by 566

  24. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)

    Authors: Diamant Thaçi, Eric L. Simpson, Mette Deleuran, Yoko Kataoka, Zhen Chen, Abhijit Gadkari, Laurent Eckert, Bolanle Akinlade, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu - Journal of Dermatological Science 2019 cited by 185